cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2015-30-2-96-101cardiotomsk-175Research ArticleВ ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУTIPS TO HELP A PRACTICAL DOCTORВозможности магнитно-резонансной томографии с парамагнитным усилением в проспективной оценке атеросклеротического процесса в динамике терапии аторвастатином на примере сонных артерийMagnetic resonance imaging with paramagnetic contrast enhancement as a tool for the control of antiatherosclerotic treatment with atorvastatine in case of carotid stenosisБобриковаЕвгения ЭдуардовнаBobrikovaE. E.bobrikova.tomsk@gmail.comМаксимоваАлександра СергеевнаMaksimovaA. S.noemail@neicon.ruЛукьяненокПавел ИвановичLukyanenokP. I.paul@cardio.tsu.ruАптекарьВладимир ДмитриевичAptekarV. D.avd@cardio-tomsk.ruПлотниковМихаил ПавловичPlotnikovM. P.noemail@neicon.ruГусаковаАнна МихайловнаGusakovaA. M.oon@cardio.tsu.ruУсовВладимир ЮрьевичUssovW. Yu.ussov1962@yandex.ruФедеральное государственное бюджетное научное учреждение "Научно-исследовательский институт кардиологии"РоссияFederal State Budgetary Scientific Institution "Research Institute for Cardiology"Russian Federation20150609201630296101Copyright © Бобрикова Е.Э., Максимова А.С., Лукьяненок П.И., Аптекарь В.Д., Плотников М.П., Гусакова А.М., Усов В.Ю., 20162016Бобрикова Е.Э., Максимова А.С., Лукьяненок П.И., Аптекарь В.Д., Плотников М.П., Гусакова А.М., Усов В.Ю.Bobrikova E.E., Maksimova A.S., Lukyanenok P.I., Aptekar V.D., Plotnikov M.P., Gusakova A.M., Ussov W.Y.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/175

Представлены и обсуждены возможности магнитно-резонансной томографии (МРТ) с контрастным усилением в проспективной оценке состояния каротидных атеросклеротических бляшек на примере двухлетнего МРТ-наблюдения пациента с двусторонним атеросклеротическим поражением каротидных артерий в динамике терапии аторвастатином (40 мг/сутки). Показано, что длительное применение аторвастатина сопровождается проспективным снижением интенсивности контрастного усиления атеросклеротических бляшек в области проксимальных отделов внутренних сонных артерий и снижением риска острых нарушений мозгового кровообращения, стабилизацией картины головного мозга.

The article presents and discusses capabilities of magnetic resonance imaging with paramagnetic contrast enhancement as a possible tool for long-term follow-up of atherosclerotic plaques. Authors present a case of following-up a patient with bilateral carotid atherosclerotic plaques treated with atorvastatine at a dose of 40 mg per day for as long as two years. Data suggest that long-term treatment with atorvastatine is associated with decrease in contrast enhancement of atherosclerotic plaques of carotid arteries and also with stabilization/improvement in MRI scans of the brain itself.

магнитно-резонансная томографиякаротидный атеросклерозконтрастное усилениеаторвастатинmagnetic resonance imagingcarotid atherosclerosiscontrast enhancementatorvastatineReferencesБобрикова Е.Э., Щербань Н.В., Ханеев В.Б. и др. Оценка состояния атеросклеротических бляшек брахиоцефальных артерий средствами высокоразрешающей контрастированной МРТ: взаимосвязь с ишемичсским повреждением головного мозга // Мед. визуализация. - 2013. - № 1. - С. 26-34.Бобрикова Е.Э., Щербань Н.В., Ханеев В.Б. и др. Оценка состояния атеросклеротических бляшек брахиоцефальных артерий средствами высокоразрешающей контрастированной МРТ: взаимосвязь с ишемичсским повреждением головного мозга // Мед. визуализация. - 2013. - № 1. - С. 26-34.Amarenco P., Labreuche J., Lavallere P., Touboul P.-J. Statin in stroke prevention and carotid atherosclerosis: systematic review and meta-analysis // Stroke. - 2004. - Vol. 35. - P. 2902-2909.Amarenco P., Labreuche J., Lavallere P., Touboul P.-J. Statin in stroke prevention and carotid atherosclerosis: systematic review and meta-analysis // Stroke. - 2004. - Vol. 35. - P. 2902-2909.Benavente O., Moher D., Pham B. Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis // BMJ. - 1998. - Vol. 317. - P. 1477-1480.Benavente O., Moher D., Pham B. Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis // BMJ. - 1998. - Vol. 317. - P. 1477-1480.Choudhury R.P., Fuster V., Badimon J.J. et al. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2002. - Vol. 22, No. 7. -P. 1065-1074.Choudhury R.P., Fuster V., Badimon J.J. et al. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2002. - Vol. 22, No. 7. -P. 1065-1074.De Boer O.J., Van Der Wal A.C., Teeling P. et al. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization // Cardiovascular Research. - 1999. - Vol. 41, No. 2. - P. 443-449.De Boer O.J., Van Der Wal A.C., Teeling P. et al. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization // Cardiovascular Research. - 1999. - Vol. 41, No. 2. - P. 443-449.Fayad Z.A., Fuster V., Fallon J.T. et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging // Circulation. - 2000. - Vol. 102, No. 5. - P. 506-510.Fayad Z.A., Fuster V., Fallon J.T. et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging // Circulation. - 2000. - Vol. 102, No. 5. - P. 506-510.Fayad Z.A., Sirol M., Moreno P.R. et al. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-m-enhanced MRI: implications for plaque vulnerability // Circulation. - 2009. - Vol. 2, No. 5. -P. 391-396.Fayad Z.A., Sirol M., Moreno P.R. et al. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-m-enhanced MRI: implications for plaque vulnerability // Circulation. - 2009. - Vol. 2, No. 5. -P. 391-396.Gresser U., Gathof B.S. Atorvastatin: gold standard for prophylaxis myocardial ischemia and stroke // Eur. J. Med. Res. - 2004. - Vol. 9. - P. 1-17.Gresser U., Gathof B.S. Atorvastatin: gold standard for prophylaxis myocardial ischemia and stroke // Eur. J. Med. Res. - 2004. - Vol. 9. - P. 1-17.Gronholdt M.L. B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis // Neuroimaging Clin. N. Am. - 2002. - No. 12(3). - P. 421-435.Gronholdt M.L. B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis // Neuroimaging Clin. N. Am. - 2002. - No. 12(3). - P. 421-435.Jiang X.B., Yuan W.S., Wang J.S. et al. Matrix metalloproteinase-9 expression in carotid atherosclerotic plaque and contrast-enhanced MRI in a swine model // Journal of Neurointerventional Surgery. - 2014. - Vol. 6, No. 1. - P. 24-28.Jiang X.B., Yuan W.S., Wang J.S. et al. Matrix metalloproteinase-9 expression in carotid atherosclerotic plaque and contrast-enhanced MRI in a swine model // Journal of Neurointerventional Surgery. - 2014. - Vol. 6, No. 1. - P. 24-28.Moreno P., Purushothaman K.R., Fuster V. et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability // Circulation. - 2004. - Vol. 110, No. 14. - P. 2032-2038.Moreno P., Purushothaman K.R., Fuster V. et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability // Circulation. - 2004. - Vol. 110, No. 14. - P. 2032-2038.Moreno P.R., Purushothaman K.-R., Sirol M. et al. Neovascularization in human atherosclerosis // Circulation. - 2006. - Vol. 113, No. 18. - P. 2245-2252.Moreno P.R., Purushothaman K.-R., Sirol M. et al. Neovascularization in human atherosclerosis // Circulation. - 2006. - Vol. 113, No. 18. - P. 2245-2252.Murphy S.L., Xu J., Kochanek K.D. Deaths: preliminary data for 2010 // National Vital Statistics Reports. - 2012. - Vol. 60, No. 4. - P. 1-51.Murphy S.L., Xu J., Kochanek K.D. Deaths: preliminary data for 2010 // National Vital Statistics Reports. - 2012. - Vol. 60, No. 4. - P. 1-51.Reith W. Extracranial carotid stenosis: diagnostics, therapy and follow-up // Radiologe. - 2013. - No. 53(6). - P. 545-560.Reith W. Extracranial carotid stenosis: diagnostics, therapy and follow-up // Radiologe. - 2013. - No. 53(6). - P. 545-560.Szapary L., Horvath B., Marton Z. et al. Short-term effect of lowdose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia // CNS Drugs. -2004. - Vol. 18. - P. 165-172.Szapary L., Horvath B., Marton Z. et al. Short-term effect of lowdose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia // CNS Drugs. -2004. - Vol. 18. - P. 165-172.Virmani R., Kolodgie F.D., Burke A.P. et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2005. - Vol. 25, No. 10. -P. 2054-2061.Virmani R., Kolodgie F.D., Burke A.P. et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2005. - Vol. 25, No. 10. -P. 2054-2061.Wagenknecht L., Wasserman B., Chambless L. et al. Correlates of carotid plaque presence and composition as measured by mri the atherosclerosis risk in communities study // Circulation. -2009. - Vol. 2, No. 4, - P. 314-322.Wagenknecht L., Wasserman B., Chambless L. et al. Correlates of carotid plaque presence and composition as measured by mri the atherosclerosis risk in communities study // Circulation. -2009. - Vol. 2, No. 4, - P. 314-322.Wagner S., Schnorr J., Ludwig A. et al. Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization // International Journal of Nanomedicine. - 2013. - Vol. 8. -P. 767-779.Wagner S., Schnorr J., Ludwig A. et al. Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization // International Journal of Nanomedicine. - 2013. - Vol. 8. -P. 767-779.Wasserman B.A., Sharrett A.R., Lai S. et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the Multi-Ethnic Study of Atherosclerosis (MESA) // Stroke. - 2008. -Vol. 39, No. 2. - P. 329-335.Wasserman B.A., Sharrett A.R., Lai S. et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the Multi-Ethnic Study of Atherosclerosis (MESA) // Stroke. - 2008. -Vol. 39, No. 2. - P. 329-335.World Health Organization, Cardiovascular diseases (CVDs) // Fact Sheet. - 2011. - No. 317.World Health Organization, Cardiovascular diseases (CVDs) // Fact Sheet. - 2011. - No. 317.Yuan C., Lin E., Millard J. et al. Closed contour edge detection of blood vessel lumen and outer wall boundaries in black-blood MR images // Magnetic Resonance Imaging. - 1999. - Vol. 17, No. 2. - P. 257-266.Yuan C., Lin E., Millard J. et al. Closed contour edge detection of blood vessel lumen and outer wall boundaries in black-blood MR images // Magnetic Resonance Imaging. - 1999. - Vol. 17, No. 2. - P. 257-266.Zhao Li, X., Liu X. et al. Evaluation of the early enhancement of coronary atherosclerotic plaque by contrast-enhanced MR angiography // European Journal of Radiology. - 2011. -Vol. 80, No. 1. - P. 136-142.Zhao Li, X., Liu X. et al. Evaluation of the early enhancement of coronary atherosclerotic plaque by contrast-enhanced MR angiography // European Journal of Radiology. - 2011. -Vol. 80, No. 1. - P. 136-142.

The authors declare that there are no conflicts of interest present.